The first human monoclonal islet cell antibodies of the IgG class (MICA 1-6) obtained from an individual with Type 1 (insulin-dependent) diabetes mellitus were cytoplasmic islet cell antibodies selected by the indirect immunofluorescence test on pancreas sections. Surprisingly, they all recognized the 64 kDa autoantigen glutamate decarboxylase. In this study we investigated which typical features of cytoplasmic islet cell antibodies are represented by these monoclonals. We show by double immunofluorescence testing that MICA 1-6 stain pancreatic beta cells which is in agreement with the beta-cell specific expression of glutamate decarboxylase. In contrast an islet-reactive IgM monoclonal antibody obtained from a pre-diabetic individual stained all islet cells but lacked the tissue specificity of MICA 1-6 and must therefore be considered as a polyreactive IgM-antibody. We further demonstrate that MICA 1~5 revealed typical features of epitope sensitivity to biochemical treatment of the target tissue which has been demonstrated for islet cell antibodies, and which has been used to argue for a lipid rather than a protein nature of target antigens. Our results provide direct evidence that the epitopes recognized by the MICA are destroyed by methanol/chloroform treatment but reveal a high stability to Pronase digestion compared to proinsulin epitopes. Conformational protein epitopes in glutamate decarboxylase therefore show a sensitivity to biochemical treatment of sections such as ganglioside epitopes. MICA 1-6 share typical features of islet cell and 64 kDa antibodies and reveal that glutamate decarboxylase-reactive islet cell antibodies represent a subgroup of islet cell antibodies present in islet cell antibody-positive sera.
The humoral autoimmune response to islet specific antigens in Type 1 (insulin-dependent) diabetes mellitus comprises a variety of islet-specific autoantibodies circulating in the serum of affected individuals. Most target molecules of the autoimmune response to islets were unknown for a long time. Therefore the variant islet cell autoantibodies were classified according to the method by which they were detected. Cytoplasmic islet cell antibodies (ICA) have been defined by a cytoplasmic staining pattern of all islet cells in histochemical tests [1, 2] and 64 kDa antibodies were defined by immunoprecipitation experiments on in vitro labelled islet cells [3] . Whereas 64 kDa antibodies were shown to recognize the beta-cell specific enzyme protein glutamate decarboxylase (GAD) [4] ICA have been suggested to recognize gangliosides and not proteins [5, 6] . Evidence supporting this claim included the similarity in biochemical properties of antigens recognized by anti-ganglioside monoclonal antibodies with that of ICA-positive sera [5] , and the observation that ICA binding to islet cells is inhibited by glycolipid extracts from human pancreas [6] . Our group recently isolated the first human monoclonal ICA of the lgG-class (MICA 1-6) derived from a patient with newly-diagnosed Type 1 diabetes [7] . MICA 1-6, which represent five different circulating primary B-lymphocyte clones from blood [7, 8] , were selected by the histochemical ICA test and surprisingly recognized GAD as a target antigen. In addition, blocking studies with ICA-positive sera provided clear evidence that GAD reactivity of ICA was not limited to the single individual from whom the MICA were derived [7] . Our data were controversial to the suggested ganglioside nature of target antigens of ICA [5, 6] .
In this study we, therefore, addressed the question which of the typical features of ICA or 64 kDa antibodies are represented by MICA 1-6. We analysed the reactivity of the MICA within the islet by double immunofluorescence staining with anti-hormone-specific antibodies and compared their tissue specificity with that of FAE7, a new 
Subjects and methods
Generation of the human monoclonal IgM-ICA FAE7. Blood was obtained after informed consent from an ICA-posifive pre-diabetic individual who acquired Type 1 diabetes 1 year after blood donation. B lymphocytes were immortalized by Epstein-Barr virus infection as described [9] and supernatants of the cultured cells were screened for ICA after 3-4 weeks by the classic indirect immunofluorescence test using fiuorescein isothiocyanate (FITC)-labelled goat anti-human IgG and IgM antibodies (Dianova, Hamburg, Germany) [10] . Single cell cloning and stabilisation of the monoclonal line was performed as described for the MICA [7] .
Immunohistochemical characterization. Species specificity and cross-reactivity of the monoclonal antibodies with different human tissues was assessed on cryostat sections using either preformed complexes of the individual MICA with peroxidase conjugated antihuman Ig antibodies [11] Pre-treatment of pancreas sections. Cryostat sections of human pancreas from a donor with blood group 0 were processed as described [5] . Sections were fixed in acetone (5 rain, 20~ or incubated in methanol/chloroform (1:2) (5 min, 20 ~ or, after acetone fixation, W. Richter et al.: Human monoclonal islet specific autoantibodies washed for 10 min in PBS and incubated with Pronase 0.1 mg/ml in PBS (Boehringer, Mannheim, Mannheim, Germany) for 10 rain at 20~ or with neuraminidase 0.5 U/ml in 50 mmol/1 sodium citrate pH 5.5 (Boehringer) for 60 rain at 37 ~ A mouse monoclonal antihuman proinsulin antibody (1:10 in PBS; Novo) was used to optimize the duration of the Pronase incubation step. The monoclonal antibody A2B5, recognizing a ganglioside antigen in islets [12] was used as a control in the neuraminidase incubation step. After pretreatment sections were washed for 15 rain in PBS and staining of the antibodies was assessed by the indirect immunofluorescence test.
Immunoblotting. GAD was purified from the cytosolic fraction of pig brain homogenates (10% weight/volume in 20 mmol/l KHzPO4 pH 7.4, 1 retool/1 phenyl-methyl-sulphonyl-fluoride, i mmol/1 amino-ethyl-isothiouronium-bromide, 0.02 retool/1 pyridoxal phosphate). The 33.000 x g supernatant was purified by gelfiltration on a Sepharose Q column and fractions with GAD enzyme activity were pooled and spotted on nitrocellulose membranes (30 btl/slot of dilutions 1:10, 1:100 and 1:500) (Hybond; Amersham, Amersham, Bucks., UK). Part of the blots were incubated in methanol/chloroform (1:2) for 5 rain (20 ~ or in Pronase (0.1 mg/m110 rain, 20 ~ After washing the nitrocellulose membranes were immunostained with supernatant of MICA 4 (2 gg/ml), a pool ofafl MICA (2 [tg/ml), an irrelevant human monoclonal antibody (2 gg/ml), or the GAD 65-specific rabbit antiserum 1267 (donated by J.Peterson, Copenhagen, Denmark). Reactivity was detected in an enhanced chemiluminescence assay (Amersham) on Kodak XO Mat film. Membranes were then washed in PBS and stained with Coomassie brilliant blue.
Results
Immunohistochemical characterization. FAE7, a human monoclonal ICA of the IgM class was derived from a prediabetic individual using the above-mentioned methods.
Reactivity of FAE7 and MICA 1-6 was analysed on different human organs and on pancreas sections of different mammalian species. In contrast to the MICA, FAE7 was not restricted to islet cells and did not cross-react with pancreas sections of the other mammalian species tested. Therefore, only MICA 1-6 exhibited a reactivity typical for ICA (Table 1) .
Cell staining within islets. As judged by double immunofluorescence staining of the monoclonal antibodies and anti-hormone specific antibodies the MICA showed a beta-cell restricted staining pattern in many islets which overlapped almost completely with that of the anti-proinsulin antibody. However, some single cells lying at the periphery of some islets, which were negative with the proinsulin antibody were weakly stained by the MICA, especially when a pooled supernatant of MICA 1-6 was applied (Fig. 1a-c) . Cells positive for anti-glucagon or anti-somatostatin antibodies were negative for the MICA when judged within the same section (Fig.ld, e and results not shown). FAE7, in contrast, reacted with all cells of the islet and in addition with single cells of the exocrine pancreas as well as with pancreatic ducts (Fig. 1 f) .
Biochemical stability of the antigenic epitopes of MICA 1- This reduction of binding, however, was non-specific since the same result was achieved when the sections were pre-incubated with the control buffer alone (50 retool/1 sodium citrate, 37~ pH 5.5). In contrast, A2B5 staining was not affected by the buffer control incubation ( Table 2 ). The biochemical stability of the epitopes recognized by MICA 3 and 4 was in line with the biochemical stability of the epitopes recognized by ICA from serum. Except for neuraminidase treatment, MICA 3 and 4 behaved similarly to the anti-ganglioside antibody A2B5. Despite recognizing protein epitopes, MICA 3 and 4 behaved differently from the anti-proinsulin antibody.
GAD was less sensitive to Pronase than proinsulin. To test whether G A D is insensitive to Pronase digestion, various
concentrations and incubation times of Pronase were applied on tissue sections. Titration studies revealed a rapid degradation of proinsulin by 0.1 mg/ml Pronase in 10-15 rain, whereas G A D epitopes recognized by the MICA remained stable during that time. A 1-h incubation with this Pronase concentration was necessary to degrade epitopes recognized by the MICA (Fig. 2) . Alternatively a 10-fold increase in Pronase concentration degraded the MICA epitopes within 15 min and proinsulin epitopes within 2 rain. G A D localized in the tissue, therefore, was much less sensitive to unspecific proteolysis by Pronase than proinsulin, but was not completely stable.
Methanol~chloroform treatment destroyed the MICA epitopes.
We investigated whether the conformational G A D epitopes recognized by MICA 3 and MICA 4 were destroyed by incubation with methanol/chloroform or whether elution of G A D from the tissue contributed to the , w h e r e a s u n t r e a t e d or P r o n a s e -t r e a t e d G A D was still reactive (Fig. 3) . A n irrelevant h u m a n m o n o c l o n a l a n t i b o d y of the I g G class did not react with any of the slots (not shown). To exclude that G A D was not e l u t e d from the nitrocellulose m e m b r a n e during m e t h a n o l / c h l o r o f o r m t r e a t m e n t , parallel blots were stained with a polyclonal serum (1267) raised against W. Richter et al.: Human monoclonal islet specific autoantibodies 
Discussion
H u m a n m o n o c l o n a l antibodies are an invaluable tool with which to study the n a t u r e of the h u m o r a l i m m u n e response associated with p a n c r e a t i c beta-cell destruction and d e v e l o p m e n t of Type 1 diabetes. We recently obt a i n e d the first h u m a n m o n o c l o n a l I C A of the IgG-class ( M I C A 1~5) derived from a patient with Type 1 diabetes. M I C A 1-6, selected by the classic I C A test of indirect imm u n o f l u o r e s c e n c e all recognized the Type 1 diabetes specific 64 k D a autoantigen G A D [7] . The epitopes recognized by the M I C A were multiple and c o m m o n for I C A from serum [7, 8] . We here asked the question w h e t h e r the islet-reactive I g G m o n o c l o n a l s M I C A 1-6 d e m o n s t r a t e all typical features of I C A . We further investigated w h e t h e r F A E 7 , a new h u m a n m o n o c l o n a l I g M -I C A isolated from a p r e -d i a b e t i c individual fits in this p a n e l of dise a s e -r e l a t e d I C A . F A E 7 was derived from b l o o d o b t a i n e d 1 y e a r b e f o r e onset of Type 1 diabetes, but the a n t i b o d y did not represent the typical features k n o w n for I C A -p o s i t i v e sera. D u e to its cross-reactivity with h u m a n pituitary cells, thyroid, exocrine p a n c r e a t i c epithelia, and pancreas ducts, F A E 7 must be c o n s i d e r e d as a polyreactive IgM a n t i b o d y like the previous islet-reactive h u m a n m o n o c l o n a l IgMantibodies derived from patients with Type 1 d i a b e t e s [13] . Such polyreactive I g M -a n t i b o d i e s also occur in nor-mal individuals unrelated to autoimmune diseases [14] . Therefore, FAE7 can give no hints on ICA-reactive targets during earlier stages of beta-cell destruction in Type 1 diabetes.
Although MICA 1-6 were isolated using the conventional test for detection of ICA, they demonstrate all the known features of GAD antibodies. Beside the precipitation of a 64 kDa protein from islets and the immunotrapping of GAD-enzyme activity from brain extracts shown previously [7] MICA 1-6 revealed here a predominantly beta-cell specific staining pattern in islets which is consistent with the beta-cell specific expression of GAD [15, 16] . In some islets, a few single cells lying in the periphery were negative for proinsulin, but were weakly stained by the MICA. As glucagon or somatostatin staining did not overlap with the MICA staining, these single cells may be identical with the GAD-containing neural cells identified recently by Sorenson et al. [17] . These neurons were reported to be localized in the islet mantle and to extend nerve cell processes into the islet. We did not, however, test the PP-cell population and cannot exclude that PP cells contribute to this staining pattern.
Only some features typical for ICA were observed for the MICA. Whereas the specificity for islet cells and the cross-reactivity with islets of different mammalian species was typical for ICA, MICA 1-6 did not show the whole islet cell staining pattern reported for many ICA-positive sera [2] . Beta-cell specific GAD-reactive ICA, therefore, exist in at least some ICA-positive sera. Since many sera from newly-diagnosed patients with Type 1 diabetes are positive for both ICA and 64 kDa antibodies [3, 18] , GAD-reactive ICA may be very commonin ICA-positive sera.
Nayak and co-workers [5] have suggested that the islet antigen responsible for the ICA staining is a monosialoganglioside. When we analysed the biochemical properties of the MICA 3 and MICA 4 epitopes in GAD they revealed the same sensitivity to chemical pre-treatment of the tissue as epitopes recognized by ICA from serum. In addition, the stability of the MICA epitopes, except for the neuraminidase sensitivity, was identical to the anti-ganglioside antibody A2B5 and to the panel of ICA positive sera analysed by Nayak and colleagues [5] . The anti-protein control antibody directed to proinsulin behaved differently. We were able to show that GAD was very stable to Pronase digestion of tissue sections. Using GAD immobilized on nitrocellulose membranes we provided clear evidence that the conformational MICA epitopes in GAD were destroyed by treatment with methanol/chloroform. No elution of GAD from nitrocellulose membranes due to methanol/chloroform treatment was evident. However, it cannot be excluded that under normal conditions in the tissue sections elution of GAD may occur as an additional effect of methanol/chloroform treatment beside epitope destruction.
Together our data demonstrate that conformational protein epitopes can share sensitivity to chemical pretreatment of the target tissue with ganglioside epitopes. Therefore, chemical pre-treatment of the tissue used in the past was not suitable to characterize the chemical nature of target antigens recognized by ICA. The IgG monoclonal antibodies MICA 1-6 share features of both ICA and 64 kDa antibodies and must be considered as beta-789 cell specific GAD-reactive ICA. These data together with data from others [19, 20] strongly suggest a heterogeneous composition of ICA in ICA-positive sera from patients with Type 1 diabetes. We demonstrated with the MICA that the protein GAD is one of the autoantigens recognized by ICA and we suggest that proteins as well as gangliosides are potential candidates for additional target antigens of ICA beside GAD.
